AHK-Cu (Copper Tripeptide AHK)

Mechanism of action in research models

AHK-Cu (Copper Tripeptide AHK) is investigated in dermal fibroblast, keratinocyte, hair-follicle, and melanocyte research models. Copper tripeptides modulate lysyl oxidase and ECM gene expression; melanocortin analogues engage MC1R/MC4R pathways in pigmentation studies; SNARE-targeting peptides are tool compounds for neuromuscular junction and exocytosis research — not cosmetic treatment claims.

HALO frames aesthetic-cluster listings as laboratory research materials with full analytical documentation. No human-use or cosmetic outcome language applies.

Research background

Copper peptide and melanocortin research examines extracellular matrix remodelling, collagen synthesis markers, and receptor selectivity in cell-based assays. AHK-Cu (Copper Tripeptide AHK) batches ship with HPLC purity and identity confirmation suitable for institutional procurement review.

Documentation and COA standards

Each HALO lot of AHK-Cu (Copper Tripeptide AHK) ships with an independent certificate of analysis documenting:

• HPLC purity — reverse-phase chromatography with ≥98% main peak by area integration
• Identity confirmation — LC-MS, ESI-MS, or MALDI-TOF as applicable to molecular weight
• Lot / batch number — must match the vial label for procurement audit trails
• Test date and method — third-party laboratory, not supplier self-reporting

Read: What is a peptide COA? · Batch-specific verification · Lab results index

Storage and handling

Store lyophilized AHK-Cu (Copper Tripeptide AHK) sealed, cold (−20 °C), dry, and protected from light until reconstitution. After reconstitution with an appropriate research diluent, follow institutional stability protocols; minimise freeze-thaw cycles and document open-vial dates in the lab log.

Tools: Peptide calculator · Lyophilized peptide guide · Stability guide